Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe PneumoniaOlivier Hermine, Robin Charreteur, Annick Tibi et al.|JAMA Internal Medicine|2020Cited by 777
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort studyCaroline Charlier, G. Akerman, Élodie Perrodeau et al.|The Lancet Infectious Diseases|2017Cited by 587
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trialPierre‐Louis Tharaux, Robin Charreteur, Gilles Pialoux et al.|The Lancet Respiratory Medicine|2021Cited by 297
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trialsIlias Ι. Siempos, Lauren Demerville, André C. Kalil et al.|EClinicalMedicine|2024Cited by 8